[go: up one dir, main page]

NO20023971D0 - Hormonterapi ved brystcancer - Google Patents

Hormonterapi ved brystcancer

Info

Publication number
NO20023971D0
NO20023971D0 NO20023971A NO20023971A NO20023971D0 NO 20023971 D0 NO20023971 D0 NO 20023971D0 NO 20023971 A NO20023971 A NO 20023971A NO 20023971 A NO20023971 A NO 20023971A NO 20023971 D0 NO20023971 D0 NO 20023971D0
Authority
NO
Norway
Prior art keywords
breast cancer
hormone therapy
hormone
therapy
breast
Prior art date
Application number
NO20023971A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023971L (no
Inventor
Giorgio Massimini
Robert Paridaens
Jean-Pierre Lobelle
Gabriella Piscitelli
Original Assignee
Pharmacia Sa Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Sa Nv filed Critical Pharmacia Sa Nv
Publication of NO20023971L publication Critical patent/NO20023971L/no
Publication of NO20023971D0 publication Critical patent/NO20023971D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20023971A 2000-03-03 2002-08-21 Hormonterapi ved brystcancer NO20023971D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0005257.1A GB0005257D0 (en) 2000-03-03 2000-03-03 Breast cancer hormonal therapy
PCT/EP2001/001883 WO2001064193A2 (en) 2000-03-03 2001-02-20 Exemestane for first-line treatment of breast cancer

Publications (2)

Publication Number Publication Date
NO20023971L NO20023971L (no) 2002-08-21
NO20023971D0 true NO20023971D0 (no) 2002-08-21

Family

ID=9886975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023971A NO20023971D0 (no) 2000-03-03 2002-08-21 Hormonterapi ved brystcancer

Country Status (21)

Country Link
US (1) US20030144259A1 (xx)
EP (1) EP1530478A2 (xx)
JP (1) JP2003525233A (xx)
KR (1) KR20020084167A (xx)
CN (1) CN1213755C (xx)
AU (1) AU2001254652A1 (xx)
BR (1) BR0108951A (xx)
CA (1) CA2401041A1 (xx)
CZ (1) CZ20022981A3 (xx)
EA (1) EA005413B1 (xx)
EE (1) EE200200479A (xx)
GB (1) GB0005257D0 (xx)
HR (1) HRP20020716A2 (xx)
HU (1) HUP0301123A3 (xx)
MX (1) MXPA02008574A (xx)
NO (1) NO20023971D0 (xx)
NZ (1) NZ521315A (xx)
PL (1) PL358542A1 (xx)
SK (1) SK11902002A3 (xx)
WO (1) WO2001064193A2 (xx)
ZA (1) ZA200207260B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8986501A (en) * 2000-09-08 2002-03-22 Pharmacia & Upjohn Spa Exemestane as chemopreventing agent
LT2269604T (lt) 2001-02-19 2016-11-10 Novartis Ag Inkstų solidinių navikų gydymas rapamicino dariniu
ATE340580T1 (de) * 2003-05-22 2006-10-15 Pantarhei Bioscience Bv Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
KR200450538Y1 (ko) * 2008-05-29 2010-10-11 최용희 보자기형배낭
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
CA2401041A1 (en) 2001-09-07
PL358542A1 (en) 2004-08-09
EA200200943A1 (ru) 2003-02-27
EE200200479A (et) 2003-12-15
US20030144259A1 (en) 2003-07-31
NO20023971L (no) 2002-08-21
SK11902002A3 (sk) 2003-05-02
CN1213755C (zh) 2005-08-10
HUP0301123A2 (hu) 2003-08-28
EA005413B1 (ru) 2005-02-24
EP1530478A2 (en) 2005-05-18
JP2003525233A (ja) 2003-08-26
CN1407896A (zh) 2003-04-02
HRP20020716A2 (en) 2003-12-31
AU2001254652A1 (en) 2001-09-12
NZ521315A (en) 2008-10-31
KR20020084167A (ko) 2002-11-04
WO2001064193A2 (en) 2001-09-07
ZA200207260B (en) 2003-09-10
MXPA02008574A (es) 2003-05-01
BR0108951A (pt) 2002-11-26
CZ20022981A3 (cs) 2003-02-12
WO2001064193A3 (en) 2002-07-25
GB0005257D0 (en) 2000-04-26
HUP0301123A3 (en) 2007-10-29
HK1053424A1 (en) 2003-10-24

Similar Documents

Publication Publication Date Title
AU2002360769A8 (en) Breast cancer expression profiling
EP1311262A4 (en) COMBINED TREATMENT AGAINST CANCER
IL251270A0 (en) Cancer treatment
EP1372736A4 (en) PREPARATIONS AGAINST CANCER FORMATION
AU2002226650A8 (en) Redox therapy for tumors
ATE430570T1 (de) Synergistische kombinationstherapie zur krebsbehandlung
EP1277472A4 (en) REMEDIES AGAINST CANCER
AR028476A1 (es) Tratamiento del cancer
IL156690A0 (en) Specific human antibodies for selective cancer therapy
EP1319403A4 (en) TREATMENTS AGAINST CANCER TOLERANT IN CISPLATIN
NO20023971D0 (no) Hormonterapi ved brystcancer
AU2002351374A8 (en) Antibodies to treat cancer
AU2001290165A8 (en) Components of canola for the treatment of cancer
AU2001288921A1 (en) Human breast cancer biomarkers
GB0026015D0 (en) Cancer treatment
EP1530720A4 (en) PROGRAM FOR EXPLOITING BREAST CANCER
AU2002360815A8 (en) Human breast cancer biomarkers
EP1463511A4 (en) COMBINATORY ANTICANCER THERAPY
IL147416A0 (en) Combined modalities for improved cancer treatment
GB2397018B (en) Combination therapy for treating disease
GB0027780D0 (en) Treating cancer
IL131335A0 (en) Emulsions for cancer treatment
FIU990263U0 (fi) Rapuneula
GB0006695D0 (en) Breast cancer markers
GB0005466D0 (en) Cancer